Q32 Bio Inc. - Common Stock (NQ:QTTB)

8.210 -0.020 (-0.24%)

Delayed Quote Updated: 12:46 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Q32 Bio Inc. - Common Stock

< Previous 1 2 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 14, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 14, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

July 11, 2025

Let's have a look at the stocks with an unusual volume in today's session.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

July 11, 2025

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

QTTB Stock Earnings: Q32 Bio Misses EPS for Q2 2024 ↗

August 08, 2024

QTTB stock results show that Q32 Bio missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 11, 2025

Via Benzinga

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗

July 11, 2025

Levi Strauss & Co. (NYSE: LEVI) stock rose as Q2 results beat expectations and full-year guidance was raised. Other gainers and losers noted.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 10, 2025

Via Benzinga

Top movers in Thursday's after hours session ↗

July 10, 2025

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

QTTB Stock Earnings: Q32 Bio Misses EPS for Q1 2024 ↗

May 09, 2024

QTTB stock results show that Q32 Bio missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Let's take a look at the stocks that are in motion in today's session. ↗

July 10, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 10, 2025

Via Benzinga

Which stocks are experiencing notable movement on Thursday? ↗

July 10, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 15, 2025

Via Benzinga

Q32 Bio Stock Turns Retail Trader Heads After FDA Grants Fast Track For Alopecia Drug ↗

May 01, 2025

Q32 Bio shares drew renewed attention on Wednesday after the FDA granted Fast Track designation to its experimental alopecia areata treatment, bempikibart. The designation could accelerate development...

Via Stocktwits

Topics Stocks

This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

February 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 11, 2024

Via Benzinga

Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast ↗

December 11, 2024

Via Benzinga

Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? ↗

December 11, 2024

Q32 Bio reports Phase 2a SIGNAL-AA trial results for bempikibart in alopecia areata, showing safety and modest efficacy. Trial expansion planned.

Via Benzinga

Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations ↗

December 11, 2024

Via Benzinga

Topics Economy

Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Treatment ↗

December 11, 2024

The company scrapped its treatment for eczema, though continues working in alopecia.

Via Investor's Business Daily

Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

December 11, 2024

Via Benzinga

8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803% ↗

August 01, 2024

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 Bio at 101%.

Via Benzinga

AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday ↗

July 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 02, 2024

Via Benzinga

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 15, 2024

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.